Steven C. Katz, MD

Publications

• Published on 11/23/2024

  Jaroch DB, Liu Y, Kim AY, Katz SC, Cox BF, Hullinger TG. Pressure-Enabled Drug Delivery Significantly Increases Intra-Arterial Delivery of Embolic Microspheres to Liver Tumors in a Porcine Model. J Vasc Interv Radiol. 2025 Mar; 36(3):499-504.e1. PMID: 39586533.

  Read at: PubMed
• Published on 7/22/2024

  Ghosh CC, Cournoyer L, Liu Y, Ballarin A, Layman IB, LaPorte J, Morrissey M, Fraser K, Perati S, Cox BF, Yakirevich E, Treaba DO, Murtha TD, Guha P, Katz SC, Davar D. Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases. J Immunother Cancer. 2024 Jul 22; 12(7). PMID: 39038918.

  Read at: PubMed
• Published on 7/3/2024

  Jaroch DB, Liu Y, Kim AY, Katz SC, Cox BF, Hullinger TG. Intra-arterial Pressure-Enabled Drug Delivery Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model. J Vasc Interv Radiol. 2024 Oct; 35(10):1525-1533.e4. PMID: 38969336.

  Read at: PubMed
• Published on 3/5/2024

  Cook K, Gupta D, Liu Y, Miller-Rosales C, Wei F, Tuttle E, Katz SC, Marshak R, Kim AY. Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastases. Curr Med Res Opin. 2024 Apr; 40(4):591-598. PMID: 38414420.

  Read at: PubMed
• Published on 6/28/2023

  Capacio BA, Shankara Narayanan JS, Vicente DA, Liu Y, LaPorte JP, Cox BF, Jaroch DB, Katz SC, White RR. Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model. Surgery. 2023 Sep; 174(3):666-673. PMID: 37391328.

  Read at: PubMed
• Published on 12/1/2022

  Patel SP, Katz SC. Novel treatment paradigms for metastatic uveal melanoma. Cancer Gene Ther. 2022 Dec; 29(12):1807-1808. PMID: 36456705.

  Read at: PubMed
• Published on 6/15/2022

  Sullivan KM, Jiang X, Guha P, Lausted C, Carter JA, Hsu C, Labadie KP, Kohli K, Kenerson HL, Daniel SK, Yan X, Meng C, Abbasi A, Chan M, Seo YD, Park JO, Crispe IN, Yeung RS, Kim TS, Gujral TS, Tian Q, Katz SC, Pillarisetty VG. Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Gut. 2023 Feb; 72(2):325-337. PMID: 35705369.

  Read at: PubMed
• Published on 6/14/2022

  Ghosh CC, Heatherton KR, Connell KPO, Alexander IS, Greer DA, LaPorte J, Guha P, Cox BF, Katz SC. Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition. Cancer Gene Ther. 2022 Dec; 29(12):1854-1865. PMID: 35697801.

  Read at: PubMed
• Published on 3/11/2022

  Guha P, Heatherton KR, O'Connell KP, Alexander IS, Katz SC. Assessing the Future of Solid Tumor Immunotherapy. Biomedicines. 2022 Mar 11; 10(3). PMID: 35327456.

  Read at: PubMed
• Published on 12/17/2021

  Chai LF, Hardaway JC, Heatherton KR, O'Connell KP, LaPorte JP, Guha P, Lopes MC, Rabinowitz BA, Jaroch D, Cox BF, Knight R, Katz SC. Antigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis Model. J Surg Res. 2022 04; 272:37-50. PMID: 34929499.

  Read at: PubMed

View 76 more publications: View full profile at BUMC